CMG제약

058820KOSDAQ

52.8 / 100

Reference Date: 2026-09-08

Financial Score21.0 / 40

News Sentiment17.8 / 25

Momentum4.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 12.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

CMG Pharmaceutical is a core subsidiary of Chabiotech Group, specializing in the R&D, production, and sales of pharmaceuticals and health functional foods. The company focuses on developing improved new drugs using its proprietary STARFILM Technology, which enables unique taste and stability in oral disintegrating films (ODF). It is expanding into high-growth sectors such as oncology, anti-aging, ophthalmology, and maternal and baby care, while also operating an animal pharmaceutical business through its subsidiaries to enhance shareholder value.

Number of Employees

206people

Average Salary

62.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.46Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-5.15Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

0.37Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲5.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼264.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.1% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 2Neutral 1Negative 2Average Sentiment Score 71

Positive
CMG제약 "기능성 신소재 3종 제품화 본격추진"
CMG제약이 차세대 기능성 신소재 상용화를 통해 시장 확장을 가속화하고 있어 긍정적인 전망을 제공합니다.
Positive
CMG제약, 차 의학연구원과 손잡고 신소재 3종 상용화 박차… ‘롱제...
CMG제약이 차 의학연구원과 협력하여 인지기능 개선 성분과 갱년기 관련 신소재의 상용화를 가속화하며, 관련 제품 출시를 준비 중이다.
Negative
동전주 퇴출·복제약 약가 개편에…중소 제약업체들 비상
중소 제약업체들의 주가 하락과 제네릭 약가 인하로 인해 경영 압박이 증가하고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 624Won52-week high 2,14052-week low 536

1-month return1.0Point

1m -12.73% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임시주주총회결과2026-09-02
Neutral반기보고서 (2026.06)2026-08-14
Neutral의결권대리행사권유참고서류2026-08-13
Neutral주주총회소집공고2026-08-13